Tax Management India. Com
Law and Practice  :  Digital eBook
Research is most exciting & rewarding
  TMI - Tax Management India. Com
Follow us:
  Facebook   Twitter   Linkedin   Telegram

Home Case Index All Cases Central Excise Central Excise + AT Central Excise - 2015 (10) TMI AT This

  • Login
  • Summary

Forgot password       New User/ Regiser

⇒ Register to get Live Demo



 

2015 (10) TMI 1839 - AT - Central Excise


Issues: Classification of Gulabari, Keora Water, and Shilajit Capsules for Central Excise Duty exemption under Notification No. 56/2002-CE.

Classification of Gulabari and Keora Water:
The dispute centered around whether the process of manufacturing Gulabari and Keora Water amounted to "manufacture" for Central Excise Duty purposes and their correct classification under the Central Excise Tariff. The appellant argued that the products were distinct from the raw materials used and should be classified under specific headings in the Tariff. The Tribunal found that the processes involved in producing these items resulted in commercially identifiable products, meeting the criteria for "manufacture." The products were held to be rightly classifiable under specific headings in the Tariff, contrary to the Department's contention. The Tribunal emphasized that the Department cannot adopt different views for the same products manufactured by the same entity in different units, ruling in favor of the appellant.

Classification of Shilajit Capsules:
Regarding Shilajit Capsules, the appellant claimed they were not generic Ayurvedic medicine but patented and proprietary (PP) medicine manufactured based on their patented formula, not conforming to the formula specified in authoritative Ayurvedic texts. The Tribunal noted that the Department failed to provide evidence that the product complied with any specific Ayurvedic text. In the absence of such proof, the Tribunal concluded that the capsules were PP medicine and not of a generic nature, allowing the appellant's classification under heading 33049011. The appellant's compliance with drug licensing requirements further supported their classification.

Conclusion:
The Tribunal allowed the appeals, providing relief to the appellant based on the findings related to the classification of Gulabari, Keora Water, and Shilajit Capsules. The judgment highlighted the importance of consistent classification practices and the need for evidence to support classification decisions, ultimately ruling in favor of the appellant's contentions.

 

 

 

 

Quick Updates:Latest Updates